Diagnostic strategies in necrotizing soft tissue infections: from clinical scores to multi-omics and machine learning

Xiaolin Ji; Xinze Li; Zhongqiu Lu

doi:10.1093/burnst/tkag028

Burns & Trauma ›› 2026, Vol. 14 ›› Issue (1) :tkag028 DOI: 10.1093/burnst/tkag028

Review

research-article

Diagnostic strategies in necrotizing soft tissue infections: from clinical scores to multi-omics and machine learning

Xiaolin Ji ¹^,²
, Xinze Li ¹^,²
, Zhongqiu Lu ¹^,²

Author information +

History +

PDF (1809KB)

Abstract

Necrotizing soft tissue infections (NSTIs) represent a group of rapidly progressing, life-threatening infections characterized by widespread tissue necrosis, systemic inflammation, and multiorgan failure. Early diagnosis remains a clinical challenge because of nonspecific initial manifestations and overlapping symptoms with other soft tissue infections. Diagnostic scoring systems such as the Laboratory Risk Indicator for Necrotizing Fasciitis score and its variants have been widely utilized to facilitate early recognition but are limited by variable sensitivity and insufficient predictive value across diverse clinical populations. Recent advances in multi-omics technologies and machine learning approaches have enabled the identification of molecular biomarkers and predictive patterns associated with NSTI onset and progression. Integration of high-dimensional omics data with clinical and imaging parameters holds potential for dynamic, real-time diagnostic support, and individualized risk stratification in the intensive care setting. This review summarizes the evolution of diagnostic strategies for NSTIs, criti- cally appraises the limitations of conventional clinical scoring systems, and examines emerging omics-based and ML-driven approaches. Finally, we propose an integrated diagnostic roadmap that aligns clinical assessment, imaging, microbiologic evaluation, host-response biomarkers, and multi-omics data to guide future research and clinical translation.

Keywords

Necrotizing soft tissue infections / Necrotizing fasciitis / Diagnostic scoring systems / Multi-omics biomarkers / Machine learning

Cite this article

Download citation ▾

Xiaolin Ji, Xinze Li, Zhongqiu Lu. Diagnostic strategies in necrotizing soft tissue infections: from clinical scores to multi-omics and machine learning. Burns & Trauma, 2026, 14 (1) : tkag028 DOI:10.1093/burnst/tkag028

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85:1454-60. https://doi.org/10.2106/00004623-200308000-00005.

[2]	Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necro- tizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg 2014; 51:344-62. https://doi.org/10.1067/j.cpsurg.2014.06.001.

[3]	Stevens DL, Bryant AE.Necrotizing soft-tissue infections. N Engl J Med 2017; 377:2253-65. https://doi.org/10.1056/NEJMra1600673.

[4]	Bhat SS, Pallavi HR, Koppolu S, Ahmed MM, Nair AU, Mad- husudhanan D. et al. Enhancing early detection of necro- tizing soft tissue infections: the role of the laboratory risk indicator for necrotizing fasciitis (LRINEC) score. Cureus 2024; 16:e61620. https://doi.org/10.7759/cureus.61620.

[5]	McDermott J, Kao LS, Keeley JA, Grigorian A, Neville A, de Virgilio C. Necrotizing soft tissue infections: a review. JAMA Surg 2024; 159:1308-15. https://doi.org/10.1001/jamasurg.2024.3365.

[6]	Pelletier J, Gottlieb M, Long B, Perkins JC Jr. Necrotizing soft tissue infections (NSTI): pearls and pitfalls for the emergency clinician. J Emerg Med 2022; 62:480-91. https://doi.org/10.1016/j.jemermed.2021.12.012.

[7]	Zhao JC, Zhang BR, Shi K, Zhang X, Xie CH, Wang J, et al. Necrotizing soft tissue infection: clinical characteristics and outcomes at a reconstructive center in Jilin Province. BMC Infect Dis 2017; 17:792. https://doi.org/10.1186/s12879-017-2907-6.

[8]	Neilly DW, Smith M, Woo A, Bateman V, Stevenson I. Necrotis- ing fasciitis in the north east of Scotland: a 10-year retrospec- tive review. Ann R Coll Surg Engl 2019; 101:363-72. https://doi.org/10.1308/rcsann.2019.0013.

[9]	Wang JM, Lim HK. Necrotizing fasciitis: eight-year experi- ence and literature review. Braz J Infect Dis 2014; 18:137-43. https://doi.org/10.1016/j.bjid.2013.08.003.

[10]	Machado N. Necrotizing fasciitis: the importance of early diagnosis, prompt surgical debridement and adjuvant ther- apy. N Am J Med Sci 2011; 3:107-18. https://doi.org/10.4297/najms.2011.3107.

[11]	Tessier JM, Sanders J, Sartelli M, Ulrych J, de Simone B, Grabowski J, et al. Necrotizing soft tissue infections: a focused review of pathophysiology, diagnosis, operative management, antimicrobial therapy, and Pediatrics. Surg Infect 2020; 21:81-93. https://doi.org/10.1089/sur.2019.219.

[12]	Johansson L, Thulin P, Low DE, Norrby-Teglund A. Get- ting under the skin: the immunopathogenesis of Strep- tococcus pyogenes deep tissue infections. Clin Infect Dis 2010; 51:58-65. https://doi.org/10.1086/653116.

[13]	Borschitz T, Schlicht S, Siegel E, Hanke E, von Stebut E. Improvement of a clinical score for necrotizing fasciitis: ‘pain out of proportion’ and high CRP levels aid the diag- nosis. PLoS One 2015; 10:e0132775. https://doi.org/10.1371/journal.pone.0132775.

[14]	Hefny AF, Eid HO, Al-Hussona M, Idris KM, Abu-Zidan FM.Necrotizing fasciitis: a challenging diagnosis. Eur J Emerg Med 2007; 14:50-2. https://doi.org/10.1097/01.mej.0000228447.48276.7b.

[15]	van Stigt SF, de Vries J, Bijker JB, Mollen RMHG, Hekma EJ, Lemson SM, et al. Review of 58 patients with necrotizing fasciitis in the Netherlands. World J Emerg Surg 2016; 11:21. https://doi.org/10.1186/s13017-016-0080-7.

[16]	Kariksiz M, Ates O. Treatment and clinical outcomes in lower extremity necrotizing soft tissue infection. Eur J Trauma Emerg Surg 2025; 51:148. https://doi.org/10.1007/s00068-025-02835-5.

[17]	Bechar J, Sepehripour S, Hardwicke J, Filobbos G. Labora- tory risk indicator for necrotising fasciitis (LRINEC) score for the assessment of early necrotising fasciitis: a systematic review of the literature. Ann R Coll Surg Engl 2017; 99:341-6. https://doi.org/10.1308/rcsann.2017.0053.

[18]	Ronan D, Holt H, Utsi L, Arunachalam N, Tate D, Lamagni T, et al. Localised increase in necrotising fasciitis associated with a shift to monomicrobial aetiology, South Yorkshire, England, 2023. J Inf Secur 2025; 90:106505. https://doi.org/10.1016/j.jinf.2025.106505.

[19]

Asai N, Ohashi W, Kishino T, Sakanashi D, Shibata Y, Kato H, et al. The combined score of quick SOFA and the charlson comorbidity index could be a poor prognostic indicator for in-hospital mortality among patients with necrotizing fasci- itis. J Infect Chemother 2021; 27:919-23. https://doi.org/10.1016/j.jiac.2021.02.024.

[20]	Dhanasekara CS, Marschke B, Morris E, Kahathuduwa CN, Dissanaike S. Global patterns of necrotizing soft tissue infec- tions: a systematic review and meta-analysis. Surgery 2021; 170:1718-26. https://doi.org/10.1016/j.surg.2021.06.036.

[21]	Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32:1535-41. https://doi.org/10.1097/01.ccm.0000129486.35458.7d.

[22]	Henry R, Matsushima K, Etzel M, Henry RN, Golden A, Wong V, et al. Utility of the laboratory risk indicator for necrotizing fasciitis score: comorbid conditions do matter. Surg Infect 2021; 22:797-802. https://doi.org/10.1089/sur.2020.398.

[23]	Abdullah M, McWilliams B, Khan SU. Reliability of the labora- tory risk indicator in necrotising fasciitis (LRINEC) score. Sur- geon 2019; 17:309-18. https://doi.org/10.1016/j.surge.2018.08.001.

[24]

Johnson LJ, Crisologo PA, Sivaganesan S, Caldwell CC, Henning J. Evaluation of the laboratory risk indicator for necrotizing fasciitis (LRINEC) score for detecting necrotizing soft tissue infections in patients with diabetes and lower extremity infection. Diabetes Res Clin Pract 2021; 171:108520. https://doi.org/10.1016/j.diabres.2020.108520.

[25]	Bennett M. Is early diagnosis of necrotizing fasciitis impor- tant? ANZ J Surg 2008; 78:947-8. https://doi.org/10.1111/j.1445-2197.2008.04710.x.

[26]

Foo RM, Tung ML, Poon LM, Chan D, Smitasin N, Koh LP, et al. Necrotizing fasciitis in hematological patients: enterobacte- riaceae predominance and limited utility of laboratory risk indicator for necrotizing fasciitis score. Open Forum Infect Dis 2015;2:ofv081. https://doi.org/10.1093/ofid/ofv081.

[27]	Rogers PJ, Lewis BM, Odak M, Bucher J.Spontaneous necro- tizing fasciitis. Cureus 2020; 12:e11880. https://doi.org/10.7759/cureus.11880.

[28]	Tan JH, Koh BT, Hong CC, Lim SH, Liang S, Chan GW, et al. A comparison of necrotising fasciitis in diabetics and non- diabetics: a review of 127 patients. Bone Joint J 2016;98- B:1563-8. https://doi.org/10.1302/0301-620X.98B11.37526.

[29]	Albasanz-Puig A, Rodriguez-Pardo D, Pigrau C, Lung M, Roldan E, Corona PS, et al. Necrotizing fasciitis in haema- tological patients: a different scenario. Ann Hematol 2020; 99:1741-7. https://doi.org/10.1007/s00277-020-04061-y.

[30]

MacLeod CS, O’Neill HL, Shaalan R, Nagy J, Flett MM, Guthrie GJK, et al. Predicting necrotising soft tissue infections in people who inject drugs: poor performance of the laboratory risk indicator for necrotising fasciitis score and development of a novel clinical predictive nomogram in a retrospective cohort with internal validation. Int J Surg 2023; 109:1561-72. https://doi.org/10.1097/JS9.0000000000000367.

[31]	Hansen MB, Rasmussen LS, Svensson M, Chakrakodi B, Bruun T, Madsen MB. et al. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospec- tive study. Sci Rep 2017; 7:42179. https://doi.org/10.1038/srep42179.

[32]	Wiggenhauser PS, Hoffmann TK. Comment on: “cervical necrotizing fasciitis-the value of the laboratory risk indicator for necrotizing fasciitis score as an indicative parameter”. J Oral Maxillofac Surg 2016; 74:1104-5. https://doi.org/10.1016/j.joms.2015.12.025.

[33]	Hsiao CT, Chang CP, Huang TY, Chen YC, Fann WC. Prospec- tive validation of the laboratory risk indicator for necrotizing fasciitis (LRINEC) score for necrotizing fasciitis of the extrem- ities. PLoS One 2020; 15:e0227748. https://doi.org/10.1371/journal.pone.0227748.

[34]	Bair MJ, Chi H, Wang WS, Hsiao YC, Chiang RA, Chang KY. Necrotizing fasciitis in Southeast Taiwan: clinical features, microbiology, and prognosis. Int J Infect Dis 2009; 13:255-60. https://doi.org/10.1016/j.ijid.2008.04.015.

[35]	Wu KH, Chang CP. Differentiating lower extremity necro- tizing soft tissue infection from severe cellulitis by labo- ratory parameters and relevant history points. Infect Drug Resist 2021;Volume 14:3563-9. https://doi.org/10.2147/IDR.S327880.

[36]

Afzal M, Saccenti E, Madsen MB, Hansen MB, Hyldegaard O, Skrede S, et al. Integrated univariate, multivariate, and correlation-based network analyses reveal metabolite- specific effects on bacterial growth and biofilm formation in necrotizing soft tissue infections. J Proteome Res 2020; 19:688-98. https://doi.org/10.1021/acs.jproteome.9b00565.

[37]

Hansen MB, Rasmussen LS, Garred P, Pilely K, Wahl AM, Perner A, et al. Associations of plasma nitrite, L-arginine and asymmetric dimethylarginine with morbidity and mor- tality in patients with necrotizing soft tissue infections. Shock 2018; 49:667-74. https://doi.org/10.1097/SHK.0000000000000975.

[38]	Imohl M, Fitzner C, Perniciaro S, van der Linden M. Epidemi- ology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS One 2017; 12:e0180757. https://doi.org/10.1371/journal.pone.0180757.

[39]	Katz S, Suijker J, Hardt C, Madsen MB, Vries AMD, Pijpe A, et al. Decision support system and outcome prediction in a cohort of patients with necrotizing soft-tissue infections. Int J Med Inform 2022; 167:104878. https://doi.org/10.1016/j.ijmedinf.2022.104878.

[40]

Jahagirdar S, Morris L, Benis N, Oppegaard O, Svenson M, Hyldegaard O, et al. Analysis of host-pathogen gene associ- ation networks reveals patient-specific response to strepto- coccal and polymicrobial necrotising soft tissue infections. BMC Med 2022; 20:173. https://doi.org/10.1186/s12916-022-02355-8.

[41]	Shumba P, Mairpady Shambat S, Siemens N. The role of streptococcal and staphylococcal exotoxins and proteases in human necrotizing soft tissue infections. Toxins (Basel) 2019; 11:332. https://doi.org/10.3390/toxins11060332.

[42]	Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 2009; 208:279-88. https://doi.org/10.1016/j.jamcollsurg.2008.10.032.

[43]	Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by community- associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53. https://doi.org/10.1056/NEJMoa042683.

[44]	Giuliano A, Lewis F Jr, Hadley K, Blaisdell FW. Bacteriology of necrotizing fasciitis. Am J Surg 1977; 134:52-7. https://doi.org/10.1016/0002-9610(77)90283-5.

[45]	Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect 2010; 75:249-57. https://doi.org/10.1016/j.jhin.2010.01.028.

[46]	Chaudhry AA, Baker KS, Gould ES, Gupta R. Necrotizing fasci- itis and its mimics: what radiologists need to know. AJR Am J Roentgenol 2015; 204:128-39. https://doi.org/10.2214/AJR.14.12676.

[47]	Glass GE, Sheil F, Ruston JC, Butler PE.Necrotising soft tissue infection in a UK metropolitan population. Ann R Coll Surg Engl 2015; 97:46-51. https://doi.org/10.1308/003588414X14055925058553.

[48]	Abad Hernandez MA. Soft-tissue infections. Reumatol Clin 2008; 4:35-40. Infeccion de partes blandas. https://doi.org/10.1016/S1699-258X(08)76166-7.

[49]

Naamany E, Shiber S, Duskin-Bitan H, Yahav D, Bishara J, Sagy I. et al. Polymicrobial and monomicrobial necrotiz- ing soft tissue infections: comparison of clinical, laboratory, radiological, and pathological hallmarks and prognosis. A retrospective analysis. Trauma Surg Acute Care Open 2021; 6:e000745. https://doi.org/10.1136/tsaco-2021-000745.

[50]	Dehority W, Wang E, Vernon PS, Lee C, Perdreau-Remington F, Bradley J. Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate. Pediatr Infect Dis J 2006; 25:1080-1. https://doi.org/10.1097/01.inf.0000243158.25713.29.

[51]	Lee YT, Lin JC, Wang NC, Peng MY, Chang FY. Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the com- munity. J Microbiol Immunol Infect 2007; 40:335-41.

[52]	Gregory CJ, Okaro JO, Reingold A, Chai S, Herlihy R, Petit S, et al. Invasive group a streptococcal infections in 10 US states. JAMA 2025; 333:1498-507. https://doi.org/10.1001/jama.2025.0910.

[53]	Bross MH, Soch K, Morales R, Mitchell RB. Vibrio vulnifi- cus infection: diagnosis and treatment. Am Fam Physician 2007; 76:539-44.

[54]	Goodell KH, Jordan MR, Graham R, Cassidy C, Nasraway SA. Rapidly advancing necrotizing fasciitis caused by Photo- bacterium (Vibrio) damsela: a hyperaggressive variant. Crit Care Med 2004; 32:278-81. https://doi.org/10.1097/01.CCM.0000104920.01254.82.

[55]	Tsai YH, Huang KC, Shen SH, Hsu WH, Peng KT, Huang TJ. Microbiology and surgical indicators of necrotizing fasciitis in a tertiary hospital of Southwest Taiwan. Int J Infect Dis 2012; 16:e159-65. https://doi.org/10.1016/j.ijid.2011.11.001.

[56]	Cheng NC, Tai HC, Chang SC, Chang CH, Lai HS. Necro- tizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis 2015; 15:417. https://doi.org/10.1186/s12879-015-1144-0.

[57]	Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, de Prost N, et al. Necrotising soft-tissue infections. Lancet Infect Dis 2023; 23:e81-94. https://doi.org/10.1016/S1473-3099(22)00583-7.

[58]

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diag- nosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10-52. https://doi.org/10.1093/cid/ciu296.

[59]	Park KH, Jung SI, Jung YS, Shin JH, Hwang JH. Marine bacte- ria as a leading cause of necrotizing fasciitis in coastal areas of South Korea. Am J Trop Med Hyg 2009; 80:646-50. https://doi.org/10.4269/ajtmh.2009.80.646.

[60]

Tsai YH, Huang TY, Kuo LT, Chuang PY, Hsiao CT, Huang KC. Comparison of surgical outcomes and predictors in patients with monomicrobial necrotizing fasciitis and sepsis caused by Vibrio vulnificus, Aeromonas hydrophila, and Aeromonas sobria. Surg Infect 2022; 23:288-97. https://doi.org/10.1089/sur.2021.337.

[61]	Becker DK, Roder M, Wagenhauser J, Eichberger S, Herten M, Dudda M. Necrotizing fasciitis that led to unexpected and fulminant deterioration in less than 24 hours: a case report. J Int Med Res 2024; 52:3000605241290480. https://doi.org/10.1177/03000605241290480.

[62]

Cheng NC, Cheng Y, Tai HC, Chien KL, Wang SH, Chen YH, et al. High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: the role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumo- niae. Int J Infect Dis 2023; 132:64-71. https://doi.org/10.1016/j.ijid.2023.04.390.

[63]	Strom MS, Paranjpye RN. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect 2000; 2:177-88. https://doi.org/10.1016/s1286-4579(00)00270-7.

[64]	Kuehl R, Tschudin-Sutter S, Siegemund M, Marsch S, Batte- gay M, Wetterauer C, et al. High mortality of non-Fournier necrotizing fasciitis with Enterobacteriales: time to rethink classification? Clin Infect Dis 2019; 69:147-50. https://doi.org/10.1093/cid/ciy1011.

[65]	Park SY, Yu SN, Lee EJ, Kim T, Jeon MH, Choo EJ, et al. Monomicrobial gram-negative necrotizing fasciitis: an uncommon but fatal syndrome. Diagn Microbiol Infect Dis 2019; 94:183-7. https://doi.org/10.1016/j.diagmicrobio.2018.12.013.

[66]	Cook DA, Heiner JP, Rao VK. Necrotizing candidal fasciitis following hip surgery. Orthopedics 1990; 13:768-70. https://doi.org/10.3928/0147-7447-19900701-14.

[67]	Jain D, Kumar Y, Vasishta RK, Rajesh L, Pattari SK, Chakrabarti A. Zygomycotic necrotizing fasciitis in immuno- competent patients: a series of 18 cases. Mod Pathol 2006; 19:1221-6. https://doi.org/10.1038/modpathol.3800639.

[68]	Tedesco S, Di Grezia M, Tropeano G, Altieri G, Brisinda G. Necrotizing soft tissue infections: a surgical narrative review. Updat Surg 2025; 77:1239-51. https://doi.org/10.1007/s13304-025-02222-0.

[69]	Ezemma O, Korman AM, Wang HE, Kaffenberger B. Diagnos- tic methods for the confirmation of non-purulent cellulitis: a review. Arch Dermatol Res 2023; 315:2519-27. https://doi.org/10.1007/s00403-023-02658-7.

[70]	Kirven RM, Wang H, Kaffenberger BH. Moving goalposts: a call for diagnostic advancements and a consensus gold- standard in patients with cellulitis to improve research rigor. J Am Coll Emerg Physicians Open 2023; 4:e12970. https://doi.org/10.1002/emp2.12970.

[71]	Goldenberg M, Wang H, Walker T, Kaffenberger BH. pseudocelluli- tis. Clinical and immunologic differences in cellulitis vs. Expert Rev Clin Immunol 2021; 17:1003-13. https://doi.org/10.1080/1744666X.2021.1953982.

[72]	Boettler MA, Kaffenberger BH, Chung CG. Cellulitis: a review of current practice guidelines and differentiation from Pseu- docellulitis. Am J Clin Dermatol 2022; 23:153-65. https://doi.org/10.1007/s40257-021-00659-8.

[73]	Lause M, Hansen E, Libson K, Pettit C, Himed S, Rismiller KP, et al. The effect of histopathologic analysis and tissue cultures on inpatient management of cellulitis: a random- ized control trial. Arch Dermatol Res 2024; 316:482. https://doi.org/10.1007/s00403-024-03224-5.

[74]	Nusbaum KB, Boettler M, Korman AM, Alavi A, Alloo A, Dissemond J, et al. Subjective assessments in pyoderma gangrenosum diagnostic frameworks undermine framework agreement. Int J Dermatol 2024; 63:e67-9. https://doi.org/10.1111/ijd.16952.

[75]	Hamann CR, Chung C, Kaffenberger BH. Pyoderma gan- grenosum associated with dulaglutide therapy. Int J Derma- tol 2019; 58:1202-4. https://doi.org/10.1111/ijd.14272.

[76]	Hoffman KP, Shearer S, Chung C, Kaffenberger JA, Kaf- fenberger BH. Clinical and therapeutic overlap of pyo- derma gangrenosum, cutaneous small vessel vasculitis, and immunoglobulin A. Int J Dermatol 2020; 59:e286-8. https://doi.org/10.1111/ijd.14841.

[77]	Demirdover C, Geyik A, Vayvada H. Necrotising fasciitis or pyoderma gangrenosum: a fatal dilemma. Int Wound J 2019; 16:1347-53. https://doi.org/10.1111/iwj.13196.

[78]	Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet’s syndrome. Front Immunol 2019; 10:414. https://doi.org/10.3389/fimmu.2019.00414.

[79]	Elbendary A, Abdel-Halim MRE, Ragab G. Updates in cutaneous manifestations of systemic vasculitis. Curr Opin Rheumatol 2022; 34:25-32. https://doi.org/10.1097/BOR.0000000000000847.

[80]

Gallardo MA, Yan A, Korman AM, Chung C, Kaffenberger BH. Unmet needs in the study of cellulitis: a response to Salle et al’s “challenges and limitations of teledermatology for skin and soft-tissue infections: a real-world study of an expert center”. J Am Acad Dermatol 2023; 88:e307-8. https://doi.org/10.1016/j.jaad.2023.02.039.

[81]	Hayeri MR, Ziai P, Shehata ML, Teytelboym OM, Huang BK. Soft-tissue infections and their imaging mimics: from celluli- tis to necrotizing fasciitis. Radiographics 2016; 36:1888-910. https://doi.org/10.1148/rg.2016160068.

[82]	Holland MJ. Application of the laboratory risk indica- tor in necrotising fasciitis (LRINEC) score to patients in a tropical tertiary referral Centre. Anaesth Intensive Care 2009; 37:588-92. https://doi.org/10.1177/0310057X0903700416.

[83]	Al-Hindawi A, McGhee J, Lockey J, Vizcaychipi M. Validation of the laboratory risk indicator for necrotising fasciitis scor- ing system (LRINEC) in a northern European population. J Plast Reconstr Aesthet Surg 2017; 70:141-3. https://doi.org/10.1016/j.bjps.2016.05.014.

[84]	Syed A, Alvin T, Fazrina A, Abdul R. Determining if pos- itive predictive value using laboratory risk indicator for necrotising fasciitis is applicable in Malaysian patients with necrotising fasciitis. Malays Orthop J 2017; 11:36-9. https://doi.org/10.5704/MOJ.1707.005.

[85]	Neeki MM, Dong F, Au C, Toy J, Khoshab N, Lee C, et al. Eval- uating the laboratory risk indicator to differentiate celluli- tis from necrotizing fasciitis in the emergency department. West J Emerg Med 2017; 18:684-9. https://doi.org/10.5811/westjem.2017.3.33607.

[86]	Narasimhan V, Ooi G, Weidlich S, Carson P. Laboratory risk indicator for necrotizing fasciitis score for early diagnosis of necrotizing fasciitis in Darwin. ANZ J Surg 2018;88:E45-9. https://doi.org/10.1111/ans.13895.

[87]	Tsai YH, Hsu RW, Huang KC, Huang TJ. Laboratory indicators for early detection and surgical treatment of vibrio necrotiz- ing fasciitis. Clin Orthop Relat Res 2010; 468:2230-7. https://doi.org/10.1007/s11999-010-1311-y.

[88]	Karnuta J, Featherall J, Lawrenz J, Gordon J, Golubovsky J, Thomas J, et al. What demographic and clinical factors are associated with In-hospital mortality in patients with necrotizing fasciitis? Clin Orthop Relat Res 2020; 478:1770-9. https://doi.org/10.1097/CORR.0000000000001187.

[89]

Breidung D, Malsagova AT, Barth AA, Megas IF, Billner M, Hitzl W, et al. Diagnostic and prognostic value of the labo- ratory risk indicator for necrotising fasciitis (LRINEC) based on an 18 years’ experience. J Plast Reconstr Aesthet Surg 2023; 77:228-35. https://doi.org/10.1016/j.bjps.2022.11.061.

[90]	Jegathesan T, Ho SWL, Tham SYY, Ang MLT. Predictors of clinical outcomes in necrotizing fasciitis: a ten year study. Int Orthop 2025; 49:2047-54. https://doi.org/10.1007/s00264-025-06608-y.

[91]	Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44:705-10. https://doi.org/10.1086/511638.

[92]	Lunar J, Ranketi SS, Owino B, Oloo M, Parker RK. Necro- tizing fasciitis: a predictable burden in rural Kenya. World J Surg 2020; 44:2919-26. https://doi.org/10.1007/s00268-020-05581-4.

[93]	Horn DL, Shen J, Roberts E, Wang TN, Li KS, O’Keefe GE, et al. Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections. J Trauma Acute Care Surg 2020; 89:186-91. https://doi.org/10.1097/TA.0000000000002636.

[94]	Wu H, Liu S, Li C, Song Z. Modified laboratory risk indi- cator for necrotizing fasciitis (m-LRINEC) score system in diagnosing necrotizing fasciitis: a nested case-control study. Infect Drug Resist 2021; 14:2105-12. https://doi.org/10.2147/IDR.S313321.

[95]	Misiakos EP, Bagias G, Papadopoulos I, Danias N, Patapis P, Machairas N, et al. Early diagnosis and surgical treatment for necrotizing fasciitis: a multicenter study. Front Surg 2017; 4:5. https://doi.org/10.3389/fsurg.2017.00005.

[96]	Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necro- tizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 1998; 64:397-400. discussion400-1.

[97]	Tarricone A, Mata K, Gee A, Axman W, Buricea C, Mandato MG, et al. A systematic review and meta-analysis of the effective- ness of LRINEC score for predicting upper and lower extrem- ity necrotizing fasciitis. J Foot Ankle Surg 2022; 61:384-9. https://doi.org/10.1053/j.jfas.2021.09.015.

[98]	Quah GS, Cheng Q, Prabhu K, Edye MB. Necrotising soft tis- sue infection in western Sydney: an 8-year experience. ANZ J Surg 2021; 91:1813-8. https://doi.org/10.1111/ans.16961.

[99]	Hosty J, Cheema A, Magdum AA. Necrotising fasciitis: clinical judgement and early multidisciplinary collaboration is the key. Age Ageing 2022;51:afab197. https://doi.org/10.1093/ageing/afab197.

[100]

Wu PH, Wu KH, Hsiao CT, Wu SR, Chang CP. Utility of modified laboratory risk indicator for necrotizing fasci- itis (MLRINEC) score in distinguishing necrotizing from non-necrotizing soft tissue infections. World J Emerg Surg 2021; 16:26. https://doi.org/10.1186/s13017-021-00373-0.

[101]

Huang KC, Tsai YH, Huang KC, Lee MS. Model for end- stage liver disease (MELD) score as a predictor and moni- tor of mortality in patients with Vibrio vulnificus necrotiz- ing skin and soft tissue infections. PLoS Negl Trop Dis 2015; 9:e0003720. https://doi:10.1371/journal.pntd.0003720.

[102]

Cribb BI, Wang MTM, Kulasegaran S, Gamble GD, Mac- Cormick AD. The SIARI score: a novel decision support tool outperforms LRINEC score in necrotizing fasciitis. World J Surg 2019; 43:2393-400. https://doi.org/10.1007/s00268-019-05061-4.

[103]

Kim MC, Kim S, Cho EB, Lee GY, Choi SH, Kim SO, et al. Utility of magnetic resonance imaging for differentiating necro- tizing fasciitis from severe cellulitis: a magnetic resonance indicator for necrotizing fasciitis (MRINEC) algorithm. J Clin Med 2020; 9:3040. https://doi.org/10.3390/jcm9093040.

[104]

Breidung D, Grieb G, Malsagova AT, Barth AA, Billner M, Hitzl W, et al. Time is fascia: laboratory and anamnestic risk indi- cators for necrotizing fasciitis. Surg Infect 2022; 23:747-53. https://doi.org/10.1089/sur.2022.222.

[105]

Yönder H, Celik M, Berhuni MS, Genç AC, Elkan H, Tatlı F, et al. Fournier’s gangrene mortality index (FGMI): a new scoring system for predicting Fournier’s gangrene mortality. Diagnostics (Basel) 2024; 14:2732. https://doi.org/10.3390/diagnostics14232732.

[106]

Kim DY, Lavasile A, Kaji AH, Nahmias J, Grigorian A, Mukher- jee K, et al. Prospective derivation and validation of a necro- tizing soft tissue infections score: an EASTmulticenter trial. J Trauma Acute Care Surg 2024; 97:910-7. https://doi.org/10.1097/TA.0000000000004374.

[107]

Norimatsu Y, Fukasawa T, Ohno Y, Norimatsu Y, Matsuda KM, Hisamoto T, et al. Validation of laboratory risk indicator for necrotizing fasciitis (LRINEC) score and establishment of novel score in Japanese patients with necrotizing fasciitis (J- LRINEC score). J Dermatol 2025; 52:439-44. https://doi.org/10.1111/1346-8138.17663.

[108]

Bolat F, Keyif MF, Sit M, Catal O, Ozer B, Erkol MH.Don’t waste time with scoring systems to predict mortality in Fournier’s Gangrene, regulate blood sugar, and defy death! Ulus Travma Acil Cerrahi Derg May 2025; 31:472-9. Fournier Gangreni’nde mortaliteyi tahmin etmek icin puanlama sistemleriyle vakit kaybetmeyin, kan sekerini duzenleyin ve olume meydan okuyun! https://doi:10.14744/tjtes.2025.40921.

[109]

Cen H, Jin R, Yin J, Wang X. Risk factors for predicting mor- tality and amputation of patients with necrotizing soft-tissue infections: retrospective analysis of 111 cases from a single medical center. Emerg Med Int 2023; 2023:1-12. https://doi.org/10.1155/2023/6316896.

[110]

Ture Z, Unuvar GK, Esmaoglu A, Ulu-Kilic A, Coruh A, Doganay M. Severe and complicated soft tissue infections: a single- centre case series. J Wound Care 2023; 32:492-9. https://doi.org/10.12968/jowc.2023.32.8.492.

[111]

Celik M, Ciftci MU, Celik S, Öztürk V, Bayrak A, Dura- maz A, et al. Can the systemic immune-inflammation index (SII) and Charlson comorbidity index (CCI) be used to predict mortality in patients with necrotizing fasciitis? Int Orthop 2024; 48:1707-13. https://doi.org/10.1007/s00264-024-06190-9.

[112]

Ling XW, Lin K, Jiang XQ, Wu Q, Liu ZJ, Li S, et al. Interna- tional normalised ratio as an independent predictor of mor- tality in limb necrotising fasciitis with sepsis. Ann R Coll Surg Engl 2021; 103:35-40. https://doi.org/10.1308/rcsann.2020.0189.

[113]

Huang TY, Peng KT, Hsiao CT, Fann WC, Tsai YH, Li YY, et al. Predictors for gram-negative monomicrobial necrotiz- ing fasciitis in southern Taiwan. BMC Infect Dis 2020; 20:60. https://doi.org/10.1186/s12879-020-4796-3.

[114]

Huang TY, Peng KT, Hsu WH, Hung CH, Chuang FY, Tsai YH. Independent predictors of mortality for Aeromonas necrotizing fasciitis of limbs: an 18-year retrospective study. Sci Rep 2020; 10:7716. https://doi.org/10.1038/s41598-020-64741-7.

[115]

Carbonetti F, Cremona A, Carusi V, Guidi M, Iannicelli E, di Girolamo M, et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and com- parison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med 2016; 121:106-21. https://doi.org/10.1007/s11547-015-0575-4.

[116]

Bruls RJM, Kwee RM. CT in necrotizing soft tissue infec- tion: diagnostic criteria and comparison with LRINEC score. Eur Radiol 2021; 31:8536-41. https://doi.org/10.1007/s00330-021-08005-6.

[117]

Burke CE, Maley OR, Mancini B, Sardesai S, Montgomery AB, King TS, et al. Factors associated with positive findings of deep infection on computed tomography among patients with extremity cellulitis. Diagnosis (Berl) 2025; 12:413-23. https://doi.org/10.1515/dx-2024-0156.

[118]

Medikonda E, Patil A, Muchchandi R, Kotennavar M, Jaju PP, Rathod S, et al. A study on the accuracy of point-of-care ultra- sound in the diagnosis and management of necrotizing fasci- itis. Cureus 2025; 17:e83814. https://doi.org/10.7759/cureus.83814.

[119]

Oi M, Maruhashi T, Asari Y. Efficacy of near-infrared spectroscopy in diagnosing skin and soft tissue infections: a single-center retrospective study. Acute Med Surg 2025; 12:e70041. https://doi.org/10.1002/ams2.70041.

[120]

Hirose Y, Yamaguchi M, Okuzaki D, Motooka D, Hamamoto H, Hanada T, et al. Streptococcus pyogenes transcrip- tome changes in the inflammatory environment of necro- tizing fasciitis. Appl Environ Microbiol 2019; 85(21):e01428-19. https://doi.org/10.1128/AEM.01428-19.

[121]

Valderrama JA, Riestra AM, Gao NJ, LaRock CN, Gupta N, Ali SR, et al. Group a streptococcal M protein activates the NLRP3 inflammasome. Nat Microbiol 2017; 2:1425-34. https://doi.org/10.1038/s41564-017-0005-6.

[122]

Vu HM, Moran TE, Liang Z, Bao YJ, Carles PG, Keane JC, et al. Group a streptococcus remains viable inside fibrin clots and gains access to human plasminogen for subsequent fibrinolysis and dissemination. Microbiol Spectrum 2025; 13:e0260724. https://doi.org/10.1128/spectrum.02607-24.

[123]

Eraso JM, Olsen RJ, Beres SB, Kachroo P, Porter AR, Nasser W, et al. Genomic landscape of Intrahost variation in group a streptococcus: repeated and abundant mutational inacti- vation of the fabT gene encoding a regulator of fatty acid synthesis. Infect Immun 2016; 84:3268-81. https://doi.org/10.1128/IAI.00608-16.

[124]

Zhu L, Olsen RJ, Horstmann N, Shelburne SA, Fan J, Hu Y, et al. Intergenic variable-number tandem-repeat polymorphism upstream of rocA alters toxin production and enhances virulence in Streptococcus pyogenes. Infect Immun 2016; 84:2086-93. https://doi.org/10.1128/IAI.00258-16.

[125]

Aswani V, Najar F, Pantrangi M, Mau B, Schwan WR, Shukla SK. Virulence factor landscape of a Staphylococcus aureus sequence type 45 strain, MCRF184. BMC Genomics 2019; 20:123. https://doi.org/10.1186/s12864-018-5394-2.

[126]

Adachi S, Takahashi T, Minami K, Kurabayashi H, Inoue H, Yonekawa C, et al. Predictors of fatal outcome after severe necrotizing fasciitis: retrospective analysis in a tertiary hos- pital for 20 years. J Orthop Sci 2021; 26:494-9. https://doi.org/10.1016/j.jos.2020.04.007.

[127]

Liu S, Zhang YL, Zhang LY, Zhao GJ, Lu ZQ. FCGR2C: an emerging immune gene for predicting sepsis outcome. Front Immunol 2022; 13:1028785. https://doi.org/10.3389/fimmu.2022.1028785.

[128]

Kishino T, Asai N, Ohashi W, Sakanashi D, Kato H, Shiota A, et al. Usefulness of serum procalcitonin for necrotizing fasciitis as an early diagnostic tool. J Infect Chemother 2021; 27:787-93. https://doi.org/10.1016/j.jiac.2021.01.002.

[129]

Kusumoto J, Iwata E, Huang W, Takata N, Tachibana A, Akashi M. Hematologic and inflammatory parameters for determin- ing severity of odontogenic infections at admission: a retro- spective study. BMC Infect Dis 2022; 22:931. https://doi.org/10.1186/s12879-022-07934-x.

[130]

Zhu JL, Gao HJ, Yin ZT. The CRP/PAB ratio outperforms the LRINEC score in early diagnosis of Fournier’s gangrene. Surg Pract Sci 2024; 19:100267. https://doi.org/10.1016/j.sipas.2024.100267.

[131]

Hansen MB. Biomarkers of necrotising soft tissue infec- tions aspects of the innate immune response. Dan Med J 2017;64:B5396.

[132]

Chella Krishnan K, Mukundan S, Alagarsamy J, Hur J, Nookala S, Siemens N, et al. Genetic architecture of group a streptococcal necrotizing soft tissue infections in the mouse. PLoS Pathog 2016; 12:e1005732. https://doi.org/10.1371/journal.ppat.1005732.

[133]

LaRock DL, Russell R, Johnson AF, Wilde S, LaRock CN. Group a streptococcus infection of the nasopharynx requires Proin- flammatory Signaling through the Interleukin-1 receptor. Infect Immun 2020; 88:e00356-20. https://doi.org/10.1128/IAI.00356-20.

[134]

Saijo Y, Ono S, Akiyama G, Sugii M, Kodama Y, Nukaga S, et al. The discrepancy between white blood cell and C-reactive protein levels in group a streptococcal necrotizing soft-tissue infections. Plast Reconstr Surg Glob Open 2025; 13:e6917. https://doi.org/10.1097/GOX.0000000000006917.

[135]

Palma, Medina LM, Rath E, Jahagirdar S, Bruun T, Madsen MB, Strålin K, et al. Discriminatory plasma biomarkers pre- dict specific clinical phenotypes of necrotizing soft-tissue infections. J Clin Invest 2021; 131:e149523. https://doi.org/10.1172/JCI149523.

[136]

Bergsten H, Madsen MB, Bergey F, Hyldegaard O, Skrede S, Arnell P, et al. Correlation between immunoglobulin dose administered and plasma neutralization of streptococ- cal superantigens in patients with necrotizing soft tissue infections. Clin Infect Dis 2020; 71:1772-5. https://doi.org/10.1093/cid/ciaa022.

[137]

Johnson SR, Benvenuti T, Nian H, Thomson IP, Baldwin K, Obremskey WT, et al. Measures of admission immuno- coagulopathy as an indicator for in-hospital mortality in patients with necrotizing fasciitis: a retrospective study. JB JS Open Access 2023;8. https://doi.org/10.2106/JBJS.OA.22.00106.

[138]

Le Breton Y, Belew AT, Freiberg JA, Sundar GS, Islam E, Lieberman J, et al. Genome-wide discovery of novel M1T1 group a streptococcal determinants important for fitness and virulence during soft-tissue infection. PLoS Pathog 2017; 13:e1006584. https://doi.org/10.1371/journal.ppat.1006584.

[139]

Vinkel J, Rib L, Buil A, Hedetoft M, Hyldegaard O. Investigat- ing the effects of hyperbaric oxygen treatment in necrotizing soft tissue infection with transcriptomics and machine learn- ing (the HBOmic study): protocol for a prospective cohort study with data validation. JMIR Res Protoc 2022; 11:e39252. https://doi.org/10.2196/39252.

[140]

Vinkel J, Buil A, Hyldegaard O. Blood from septic patients with necrotising soft tissue infection treated with hyperbaric oxygen reveal different gene expression patterns compared to standard treatment. BMC Med Genet 2025; 18:12. https://doi.org/10.1186/s12920-024-02075-3.

[141]

Chang CP, Wu KH. Machine learning approach to classify Vibrio vulnificus necrotizing fasciitis, non-vibrio necrotizing fasciitis and cellulitis. Infect Drug Resist 2024; 17:5513-21. https://doi.org/10.2147/IDR.S487893.

[142]

Chang CP, Lin CJ, Fann WC, Hsieh CH. Identifying necro- tizing soft tissue infection using infectious fluid analysis and clinical parameters based on machine learning algo- rithms. Heliyon 2024; 10:e29578. https://doi.org/10.1016/j.heliyon.2024.e29578.

[143]

Saccenti E, Svensson M. Systems biology and biomark- ers in necrotizing soft tissue infections. Adv Exp Med Biol 2020; 1294:167-86. https://doi.org/10.1007/978-3-030-57616-5_11.

[144]

Zhou L, Li H, Luo G, the CANF experts group representing the Chinese Burn Association, Editorial Board of the Chi- nese Journal of Burns and Wounds, Burn Medicine Branch of China International Exchange and Promotion Associa- tion for Medical and Healthcare. Consensus on the diag- nosis and treatment of adult necrotizing fasciitis (2025 edition). Burns Trauma 2025;13:tkaf031. https://doi.org/10.1093/burnst/tkaf031.